论文部分内容阅读
目的探讨黄芪注射液在结核病患者临床治疗中的应用价值。方法回顾性分析2012年1月至2014年11月在长春市南关区疾病预防控制中心接受治疗的结核病患者98例,按随机数字表法将其分为对照组和观察组,各49例。对照组患者采用基础抗结核药物进行治疗,观察组患者在对照组基础上联合使用黄芪注射液,比较两组患者的痰集菌转阴率。结果观察组患者痰集菌转阴率明显高于对照组,差异有统计学意义(P<0.05)。结论黄芪注射液联合化疗药物治疗结核病临床疗效明显,能明显提高痰集菌转阴率。
Objective To investigate the value of astragalus injection in the clinical treatment of tuberculosis patients. Methods A retrospective analysis of 98 cases of tuberculosis patients treated in Nanguan District Center for Disease Control and Prevention from January 2012 to November 2014 in Changchun was conducted and divided into control group and observation group according to random number table. Patients in the control group were treated with basic anti-tuberculosis drugs. Patients in the observation group were treated with astragalus injection on the basis of the control group, and the negative rate of sputum collection was compared between the two groups. Results In the observation group, the negative rate of sputum collection bacteria was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Conclusion Astragalus injection combined with chemotherapy drugs in the treatment of tuberculosis clinical curative effect is obvious, can significantly increase the sputum bacteria negative conversion rate.